Protein chips for HPV detection

Details Protein chips for HPV detection Protein chips for HPV detection

2011-07-05

2011-07-05

Salimi, Ali R. (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

Reexamination Certificate

active

07972776

ABSTRACT:
Embodiments of the invention provide methods, assays, and kits for detecting HPV infection, including infection by various HPV genotypes, early and/or late HPV-associated or HPV-specific proteins or antibodies. Detection of HPV DNAs, genomes, and/or oncoproteins by protein chips immunological assays can be used in early clinical screening for HPV infection and general diagnosis for cervical cancer and can be advantageous performed in a multiplexed test. Comparative detection of altered levels of HPV proteins and host proteins can performed in one or more assays. The polypeptides, recombinant proteins, antibodies, nucleic acids, and various detection methods thereof are particularly useful for diagnosing carcinomas of the uterine cervix and those at risk of developing cervical cancer.

REFERENCES:
patent: 3633999 (1972-01-01), Buckles
patent: 4511220 (1985-04-01), Scully
patent: 4619508 (1986-10-01), Shibuya et al.
patent: 4744615 (1988-05-01), Fan et al.
patent: 4851978 (1989-07-01), Ichihara
patent: 5045447 (1991-09-01), Minson
patent: 5057411 (1991-10-01), Lancaster et al.
patent: 5061025 (1991-10-01), Debesis
patent: 5109465 (1992-04-01), Klopotek
patent: 5224200 (1993-06-01), Rasmussen et al.
patent: 5233460 (1993-08-01), Partlo et al.
patent: 5307207 (1994-04-01), Ichihara
patent: 5315427 (1994-05-01), Rauch et al.
patent: 5328785 (1994-07-01), Smith et al.
patent: 5357365 (1994-10-01), Ipposhi et al.
patent: 5401627 (1995-03-01), Dillner et al.
patent: 5415995 (1995-05-01), Schoolnik et al.
patent: 5453814 (1995-09-01), Aiyer
patent: 5561081 (1996-10-01), Takenouchi et al.
patent: 5591574 (1997-01-01), Orth et al.
patent: 5610733 (1997-03-01), Feldman et al.
patent: 5621529 (1997-04-01), Gordon et al.
patent: 5629161 (1997-05-01), Muller et al.
patent: 5662410 (1997-09-01), Suganuma
patent: 5665535 (1997-09-01), Orth et al.
patent: 5679509 (1997-10-01), Wheeler et al.
patent: 5699191 (1997-12-01), Fork
patent: 5754278 (1998-05-01), Kurtz
patent: 5876723 (1999-03-01), Cole et al.
patent: 5888888 (1999-03-01), Talwar et al.
patent: 5914389 (1999-06-01), Huibregtse et al.
patent: 6013262 (2000-01-01), Frazer et al.
patent: 6228578 (2001-05-01), Impraim et al.
patent: 6355424 (2002-03-01), Lorinez et al.
patent: 6420106 (2002-07-01), Gyllensten et al.
patent: 6489105 (2002-12-01), Matlashewski et al.
patent: 6524825 (2003-02-01), Mizzen et al.
patent: 6709832 (2004-03-01), Von Knebel Doeberitz et al.
patent: 6743593 (2004-06-01), Hu
patent: 6827933 (2004-12-01), Orth et al.
patent: 6884786 (2005-04-01), Kieny et al.
patent: 6890514 (2005-05-01), Mathur et al.
patent: 6900035 (2005-05-01), Mizzen et al.
patent: 6933123 (2005-08-01), Hu et al.
patent: 7157233 (2007-01-01), Fischer et al.
patent: 7361460 (2008-04-01), Williams et al.
patent: 7399467 (2008-07-01), Lu et al.
patent: 7455973 (2008-11-01), Fischer et al.
patent: 7501261 (2009-03-01), Meijer et al.
patent: 7510838 (2009-03-01), Fischer et al.
patent: 2001/0034021 (2001-10-01), Muller et al.
patent: 2004/0170644 (2004-09-01), Mailere et al.
patent: 2004/0175695 (2004-09-01), Debad et al.
patent: 2004/0260157 (2004-12-01), Montes et al.
patent: 2005/0037017 (2005-02-01), Mizzen et al.
patent: 2005/0037342 (2005-02-01), Mathur et al.
patent: 2005/0142541 (2005-06-01), Lu et al.
patent: 2005/0147621 (2005-07-01), Higgins et al.
patent: 2005/0255460 (2005-11-01), Lu et al.
patent: 2005/0255468 (2005-11-01), Ridder et al.
patent: 2005/0260566 (2005-11-01), Fischer et al.
patent: 2006/0002929 (2006-01-01), Khare et al.
patent: 2006/0029943 (2006-02-01), Hermonat et al.
patent: 2006/0039919 (2006-02-01), Chang et al.
patent: 2006/0121516 (2006-06-01), Norman et al.
patent: 2006/0147906 (2006-07-01), Zwerschke et al.
patent: 2006/0153864 (2006-07-01), Gissmann et al.
patent: 2006/0172285 (2006-08-01), Patterson
patent: 2006/0257849 (2006-11-01), Zauderer et al.
patent: 2006/0286595 (2006-12-01), Fischer et al.
patent: 2007/0048833 (2007-03-01), Sprencher et al.
patent: 2007/0059319 (2007-03-01), Carlson et al.
patent: 2007/0065810 (2007-03-01), Schlegel et al.
patent: 2007/0117167 (2007-05-01), Malinowski et al.
patent: 2007/0166699 (2007-07-01), Gissmann et al.
patent: 2007/0190062 (2007-08-01), Malinowski et al.
patent: 2007/0190529 (2007-08-01), Ridder et al.
patent: 2009/0047660 (2009-02-01), Lu et al.
patent: 2009/0075377 (2009-03-01), Lu et al.
patent: 2009/0148864 (2009-06-01), Fischer et al.
Christensen et al, Virology, 1996, vol. 223, pp. 174-184.
Nomine et al, Protein Engineering, 2001, vol. 14, No. 4, pp. 297-305.
Bosch F X, Manos M M, Munoz N, et al 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796-802.
Kiviat N B, and Koutsky L A. 1993. Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: implications for current views and tr.
Koutsky L A, Holmes K K, Critchlow C W, et al. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
Kuroda M, Kiyono T, Oikawa K, Yoshida K, Mukai K. 2005. The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target. Br J Cance.
Lehtinen M, Luukkaala T Wallin K L, et al. 2001. Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable.
Li T, Zhao L, Liu Z, Han Y, and Fan D. 2005. Regulation of apoptosis by papillomavirus E6 oncogene. World J Gastroenterol 11:931-37.
Longworth M S, Laimins L A, 2004. Pathogenesis of human papillomavirus in differentiating epithelia. Microbiol Mol Biol Rev 68: 362-72.
Madrigal M, Janicek M F, Sevin B U, et al. 1997. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Gynecol Oncol 64: 18-25.
Mougin C, Dalstein V, Pretet J L, et al. 2001. Epidemiology of cervical papillomavirus infections. Recent knowledge. Press Med 30: 1017-23.
Munoz N, Bosch X, Sanjose S, Herrero R, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N ENGL J MED 348:518-27.
Park T W, fujiwara H, Wright T C. 1995. Molecular biology of cervical cancer and its precursors. Cancer 76: 1902-13.
Wang H L, Lu D W. 2004. Detection of human papillomavirus DNA and expression of p16, Rb, p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol. 28:.
Walboomers J M, Meichers W J, Manos M M, et al. 1999. Human papilomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:12-19.
de Villiers E. M. 1997. Papillomavirus and HPV typing. Clin. Dermatol 15:199-206.
Zur Hausen, H. 2002. Papillomavirus and cancer: from basic studies to clinical application. Nat. rev. Cancer 2: 342-350.
Parkin D M, Pisant P. and ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606.
Solomon D, Davey R, Kurman R A, et al. 2002. The 2001 Bethesda Systems. Terminology for reporting results of cervical cytology. JAMA 287:2114-19.
Guimaraes M C, Goncalves M A, Soares C P, et al. 2005. Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous.
Sasagawa T, Rose RC, Azar KK, Sakai A, Inoue M. 2003. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.Int J Cancer. Apr. 10, 2003;104(3):32.
Fisher, et al. “The Association of Human Papillomavirus Type 16 E6 and E7 Antibodies with stage of Cervical Cancer”, Gynecologic Oncology 61, 73-78 (1996) Article No. 0099.
Veress, et al. “Human Papillomavirus DNA and Anti-HPV Secretory IgA Antibodies in Cytologically Normal Cervical Specimens” Journal of Medical Virology 43:201-207 (1994).
Meschede, et al. “Antibodies agains Early Proteins of Human Papillomaviruses as Diagnostic Markers for Invasive Cervical Cancer” Journal of Clinical Microbiology Feb. 1998, pp.
Park, et al. “HPV-16-Related Proteins as the Serolgic Markers in Cervical Neoplasia”, Gynecologic Oncology 69, 47-55 (1998).
Vis

Affiliated with

Also associated with

Rating

Protein chips for HPV detection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein chips for HPV detection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein chips for HPV detection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2649051